Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 5/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 8/20 | 0.73 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.73 |
| ▸ | NQO2 | P16083 | 4/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9036138 | 1.00 | ESR1 (1.00) | ESR1ESR2PTGS1PTGS2NQO2 | |
| SCHEMBL7759808 | 1.00 | ESR1 (1.00) | ESR1ESR2PTGS1PTGS2NQO2 | |
| SCHEMBL375017 | 1.00 | ESR1 (1.00) | ESR1ESR2PTGS1PTGS2NQO2 | |
| SCHEMBL9036145 | 1.00 | ESR1 (1.00) | ESR1ESR2PTGS1PTGS2NQO2 | |
| Phenol SCHEMBL9037691 | 0.92 | ESR1 (0.84) | ESR1ESR2PTGS1PTGS2NQO2 | |
| Phenol SCHEMBL9037693 | 0.92 | ESR1 (0.84) | ESR1ESR2PTGS1PTGS2NQO2 | |
| SCHEMBL900960 | 0.90 | ESR1 (0.81) | ESR1ESR2PTGS1PTGS2NQO2 | |
| SCHEMBL900961 | 0.90 | ESR1 (0.81) | ESR1ESR2PTGS1PTGS2NQO2 | |
| Cyanate SCHEMBL8394895 | 0.90 | ESR1 (0.81) | ESR1ESR2PTGS1PTGS2NQO2 | |
| SCHEMBL900999 | 0.90 | ESR1 (0.81) | ESR1ESR2PTGS1PTGS2NQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197936-A1 | SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF | Hexion Research Belgium SA (BE) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049192-A1 | SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF | HEXION INC. (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090439-A1 | SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-03-31 | — | — | US | claimed |
| EP-2669306-B1 | Process for manufacturing an epoxy resin | SOLVAY (BE) | 2015-08-12 | — | — | EP | claimed |
| EP-2895449-A1 | PROCESS OF STRIPPING A LIQUID MEDIUM | Solvay SA (BE) | 2015-07-22 | — | — | EP | claimed |
| WO-2015074684-A1 | PROCESS FOR MANUFACTURING AN EPOXY RESIN | SOLVAY SA (BE) | 2015-05-28 | — | — | WO | claimed |
| WO-2014040883-A1 | PROCESS OF STRIPPING A LIQUID MEDIUM | SOLVAY SA (BE) | 2014-03-20 | — | — | WO | claimed |
| EP-2669307-A1 | Process for manufacturing an epoxide | SOLVAY SA (BE) | 2013-12-04 | — | — | EP | claimed |
| EP-2669308-A1 | Process for manufacturing an epoxy resin | SOLVAY SA (BE) | 2013-12-04 | — | — | EP | claimed |
| EP-2669247-A1 | Process for manufacturing dichloropropanol | SOLVAY SA (BE) | 2013-12-04 | — | — | EP | claimed |
| US-5248360-A | Saturating fiber substrates with curable thermosetting resin, arranging substrates into desired configuration, curing with application of heat and pressure | THE DOW CHEMICAL COMPANY (US) | 1993-09-28 | — | — | US | claimed |
| US-5235008-A | Curable | THE DOW CHEMICAL COMPANY (US) | 1993-08-10 | — | — | US | claimed |
| US-5227452-A | Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions | THE DOW CHEMICAL COMPANY (US) | 1993-07-13 | — | — | US | claimed |
| US-5218062-A | Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions | THE DOW CHEMICAL COMPANY (US) | 1993-06-08 | — | — | US | claimed |
| US-5182340-A | Molding materials having shorter gel time with aliphatic amine curing agents | THE DOW CHEMICAL COMPANY (US) | 1993-01-26 | — | — | US | claimed |
| WO-1992015630-A2 | MESOGENIC GLYCIDYL AMINES | THE DOW CHEMICAL COMPANY (US) | 1992-09-17 | — | — | WO | claimed |
| EP-0475238-A2 | Mesogenic glycidyl esters | THE DOW CHEMICAL COMPANY (US) | 1992-03-18 | — | — | EP | claimed |
| EP-0473935-A2 | Curable mixture of mesogenic epoxy resins and mesogenic polyamines and cured compositions | THE DOW CHEMICAL COMPANY (US) | 1992-03-11 | — | — | EP | claimed |
| EP-0409069-A2 | Mesogenic polycyanates and thermosets thereof | THE DOW CHEMICAL COMPANY (US) | 1991-01-23 | — | — | EP | claimed |
| EP-0379057-A2 | Mesogenic epoxy compounds | THE DOW CHEMICAL COMPANY (US) | 1990-07-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090439-A1 | SILANE FUNCTIONALIZED COMPOUNDS AND COMPOSITIONS THEREOF | ILK, CAD, CAPG | ESR1 108/4885ESR2 425/4885PTGS1 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.